3Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE. Infectious Diseases, 2008, 197(8): 1079-1081.
4Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clinical Infectious Diseases, 2008, 46(2): 155-164.
5McGregor A, Dovey S, Tilyard M. Antibiotic use in upper respiratory tract infections in New Zealand. Family Practice, 1995, 12(2): 166-170.
6Grigoryan L, Burgerhof JG, Degener JE, Deschepper R, Lundborg CS, Monnet DL, Scicluna EA, Birkin J, Haaijer-Ruskamp FM. Determinants of self-medication with antibiotics in Europe: The impact of beliefs, country wealth and the healthcare system. Antimicrobial Chemotherapy, 2008, 61(5): 1172-1179.
7Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C, Goossens H. ESAC Project Group. European sSurveillance of antimicrobial consumption (ESAC): Outpatient antibiotic use in Europe. Antimicrobial Chemotheray, 2006, 58(2): 401-407.
8Genevieve C, Michal A, Dale D, Robyn T. Are physicians with better clinical skills on licensing examinations less likely to prescribe antibiotics for viral respiratory infections in ambulatory care settings? Medical Care, 2011, 49(2): 156-165.
9Pan Y, Henderson J, Britt H. Antibiotic prescribing in Australian general practice: How has it changed from 1990-91to 2002-03? Respiratory medicine, 2006, 100(11): 2004-2011.
10Ineke W, Marijke K, Arno H, Theo V. Antibiotics for acute respiratory tract symptoms: Patients\' expectations, GPs\' management and patient satisfaction. Family Practice, 2004, 21(3): 234-237.
